ECDC Point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals Forms V4.2.

Slides:



Advertisements
Similar presentations
European Surveillance of Surgical Site Infections and ICU-acquired Infections, Carl Suetens Surveillance Unit European Centre for Disease Prevention.
Advertisements

European Centre for Disease Prevention and Control
Developing a Framework for Estimation of Healthcare-Associated Infection Burden at the National and State Level Matthew Wise, MPH, PhD Epidemiologist,
HICC An Infection Control Committee provides a forum for multidisciplinary input and cooperation, and information sharing This committee should include.
Completing Ward List (Form A) & determining eligible patients for PPS PPS Data Collector Training April 2012 Presentation 2.
Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Antimicrobial Use & Case.
Information for Action Point Prevalence Survey of Healthcare associated infection and antimicrobial use 26 th June 2012 Dafydd Williams.
Hospital Surveillance. Impact of infectious diseases  IDs are considered to be the leading cause of death  Mass population movement  Emerging and re-emerging.
Case Report Form Start-up Meeting March 25, 2010 Kingston, ON.
QUESTIONS AND ANSWERS. A patient is admitted to the surveillance specialty with a catheter in situ Are they included in CAUTI surveillance?
PPS Data Collector Training April 2012
Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Background & Introduction.
The epidemiology of HAI Scotland Dr Jacqui Reilly Consultant Epidemiologist Head of HAI and IC Group.
HCAHPS Hospital Consumer Assessment of Healthcare Providers and Systems.
Improving the quality of medical and surgical care NCEPOD SEPSIS STUDY.
Part I BACKGROUND VENTILATOR ASSOCIATED PNEUMONIA.
OVERVIEW AND COMPLETING THE QUESTIONNAIRES - Part 1 LECTURE 2.
ECDC Point prevalence survey of healthcare- associated infections and antimicrobial use in acute care hospitals Forms V4.2.
Ward Name Date Ward Type No. Beds Sister Nurse No. Nurse Name Nurse exp. Patient No. Patient Name Bed No. Date Admitted Date ExpLeave. UNFINF2NF3NF.
Healthcare-associated infections & antimicrobial use in long-term care facilities (HALT) 2016 Training Day: Lecture 1 Welcome & Introduction to HALT 2016.
NOSOCOMIAL INFECTIons (HOSPITAL ACQUIRED INFECTIONS) by lovella d
Harm from Invasive Devices Dr. Eleri Davies, Faculty Lead HCAI.
TIPS FOR COMPLETING CRF’S October Antimicrobial Report Form 7  In iDataFax use the drop-down list to record the Antimicrobial Code. This will.
CQC National In Patient
ECDC Point Prevalence Survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2016–2017 Protocol v5.3 Forms.
PPS Data Collector Training April 2017
Søren Marker Jensen, MD, coordinating investigator
Antibiotics: handle with care!
Invasive Devices WebEx
Agents Intervening against Delirium in Intensive Care Unit (AID-ICU): An international inception cohort study Primary investigator: Marie Oxenboell-Collet.
The Four Data Entry Fields
Agents Intervening against Delirium in Intensive Care Unit (AID-ICU): An international inception cohort study Primary investigator: Marie Oxenboell-Collet.
Welcome Dr. Eleri Davies, Faculty Lead HCAI.
CRE prevalence among patients with no prior history of carriage
ECDC Point Prevalence Survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2017 Belgian Forms.
HCF (not BMC) Associated Association Indeterminate
Hospital acquired infections
Networks of hospitals: building a common strategy for HAI prevention and control and antimicrobial policy Tomasz Ozorowski, M.D. University of Medical.
Nosocomial Infections
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
2.13 Copyright UKCS #
Introduction to CAUTI and CLABSI Initiatives
GLOBAL POINT PREVALENCE SURVEY
Local organisation of the ECDC PPS
Reducing Mortality and Harm
Antimicrobial use in the 2012 PPS
APIC Chapter 13 Journal Club
Interpretation of local, national and European level results
ECDC PPS data collection tools
ECDC point prevalence survey (PPS)
Hospital Antibiotic Stewardship Programs
Data collection methods
Hospital organization, management, and structure for the infection prevention and control of healthcare-associated infection in Chinese hospitals:
Welcome / Croeso Dr. Eleri Davies
VP for Patient Safety and Quality
2018 Annual Data Report Volume 1: Chronic Kidney Disease
Sources of data (HCAI) Dr Wendy Harrison
Point prevalence survey epidemiology
GLOBAL POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE (GLOBAL-PPS): RESULTS OF ANTIMICROBIAL PRESCRIBING IN INDIA Dr. Sanjeev K Singh.
Inside COMBACTE network: global information for a global problem.
Background and Context
* * * * * * * * * Form H: Hospital-based data by surveillance period
MRSA=Methicillin resistant Staphylococcus aureus
Implementing innovation when financial times are hard
To Dip Or Not To Dip – Improving the management of Urinary Tract Infection in older people Improving Patient Safety & Care 6th Feb 2019 Continuous Learning,
Ventilator Associated Pneumonia
Tony Crockford & Muhammad Sartaj.
Point prevalence survey (PPS) of healthcare associated infections (HAI) & antimicrobial use (AMU) in acute care Mark McConaghy, Dr Muhammad Sartaj,
Introduction to epidemiology
Preventing Venous Thromboembolism Participating Hospital Survey
Presentation transcript:

ECDC Point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals Forms V4.2

Form N. National/regional data European Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use Form N. National/regional data Country Code: _____ Network ID/Data Source: _____ Date start PPS : __ / __ /____ National/regional PPS coordination centre/institute: ________________________________________________ National/regional PPS coordination programme/unit: Name: ____________________________________________ Website: __________________________________________  N Year data Total N of acute care hospitals (“sites”)   N of hospital mergers (“trusts”) Total N of beds in acute care hospitals Total N of acute care beds Number of discharges/admissions, all Number of discharges/admissions, acute care beds only Number of patient days, all Number of patient days, acute care beds only Method of sampling/recruitment of hospitals (more than 1 answer possible): O representative systematic random sample O other representative sample O convenience sample (selection) O all hospitals invited O voluntary participation O mandatory participation Total number of hospitals in PPS: Light (unit-based) protocol ____ Standard (patient-based) protocol _____ Number of hospitals submitted to ECDC: Light (unit-based) protocol ____ Standard (patient-based) protocol _____ Comments/observations: __________________________________________________________________________________________ _______________________________________________________________________________________________________________

 Yes, please specify which ward types were excluded: European Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use Form H. Hospital data Hospital code: Survey dates: From __ / __ /____ To: __ / __ / ____ dd / mm / yyyy dd / mm / yyyy Hospital size (total number of beds) Number of acute care beds Number of ICU beds Exclusion of wards for PPS?  No  Yes, please specify which ward types were excluded: _______________________________________________ Total number of beds in included wards: Total number of patients included in PPS: Hospital Type  Primary  Secondary  Tertiary  Specialized, please specify Specialization type: ______________________  Number Year data Incl. wards/ Total (1) Number of discharges/admissions in year   Inc Tot Number of patient days in year Alcoholic hand rub consumption liters/year Number of patient rooms in hospital Number of single patient rooms in hospital Number of FTE infection control nurses Number of FTE infection control doctors (1) Data were collected for Included wards only (Inc , = recommended) or for the total hospital (Tot); if all wards were included in PPS (Inc=Tot), mark “Inc” Data apply to:  Single hospital or hospital site  Hospital “trust” or merger PPS Protocol:  Standard  Light Comments/observations: ___________________________ ______________________________________________ Below: To be filled/checked by national coordinator Is the hospital part of a national representative sample of hospitals ?  No  Yes  Unknown

Form A. Patient-based data (standard protocol) European Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use Form A. Patient-based data (standard protocol) Antimicrobial (generic or brand name) Route Indication Diagnosis (site) Reason in notes   Patient data (to collect for all patients) Hospital code Ward name (abbr.)/Unit Id Ward specialty Survey date: ___ / ___ / _______ (dd/mm/yyyy) Patient Counter: _________________________________ Age in years: ____ yrs; Age if < 2 year old: _____ months Sex: M F Date of hospital admission: ___ / ___ / _____ Consultant/Patient Specialty: Surgery since admission: O No surgery O Minimal invasive/non-NHSN surgery O NHSN surgery O Unknown McCabe score: O Non-fatal disease O Ultimately fatal disease O Rapidly fatal disease O Unknown Central vascular catheter: O No ,O Yes O Unk Peripheral vascular catheter: O No O Yes O Unk Urinary catheter: O No O Yes O Unk Intubation: O No O Yes O Unk Patient receives antimicrobial(s)(1): O No O Yes Patient has active HAI(2): O No O Yes Route: P: parenteral, O: oral, R: rectal, I: inhalation; Indication: CI - LI - HI: treatment intention for community-acquired (CI), long/intermediate-term care-acquired (LI) or acute hospital-acquired infection (HI); surgical prophylaxis: SP1: single dose, SP2: one day, SP3: >1day; MP: medical prophylaxis; O: other; UI: Unknown indication; Diagnosis: see site list, only for treatment intention Reason in notes: Y/N dd / mm / yyyy HAI 1 HAI 2 HAI 3 Case definition code   Relevant device in situ before onset(3) O Yes O No O Unknown O Yes O No Present at admission Date of onset(4) ___ / ___ / _____ Origin of infection O current hospital O other hospital O other origin/ unk If BSI: source(5) MO-code R(6) Microorganism 1 Microorganism 2 Microorganism 3 IF YES (1) At the time of the survey, except for surgical prophylaxis 24h before 8:00 AM on the day of the survey; if yes, fill antimicrobial use data; (2) [infection with onset ≥ Day 3, OR SSI criteria met (surgery in previous 30d/1yr), OR discharged from acute care hospital <48h ago, OR CDI and discharged from acute care hospital < 28 days ago OR onset < Day 3 after invasive device/procedure on D1 or D2] AND [HAI case criteria met on survey day OR patient is receiving (any) treatment for HAI AND case criteria are met between D1 of treatment and survey day]; if yes, fill HAI data (3) relevant device use (intubation for PN, CVC/PVC for BSI, urinary catheter for UTI) in 48 hours before onset of infection (even intermittent use), 7 days for UTI; (4) Only for infections not present/active at admission (dd/mm/yyyy); (5) C-CVC, C-PVC, S-PUL, S-UTI, S-DIG, S-SSI, S-SST, S-OTH, UO, UNK; (6) AMR marker 0,1,2 or 9, see table

Form B2. Light option: Antimicrobial use and HAI data European Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use Form B2. Light option: Antimicrobial use and HAI data Antimicrobial (generic or brand name) Route Indication Diagnosis (site) Reason in notes   Patient data (patients with HAI and/or antimicrobial only) Hospital code Ward name (abbr.)/Unit Id Patient Counter: _________________________________ Age in years: ____ yrs; Age if < 2 years old: _____ months Sex: M F Date of hospital admission: ___ / ___ / _____ (dd/mm/yyyy) Consultant/Patient Specialty: Patient receives antimicrobial(s)(1): O No O Yes Patient has active HAI(2): O No O Yes Route: P: parenteral, O: oral, R: rectal, I: inhalation; Indication: CI - LI - HI: treatment intention for community-acquired (CI), long/intermediate-term care-acquired (LI) or acute hospital-acquired infection (HI); surgical prophylaxis: SP1: single dose, SP2: one day, SP3: >1day; MP: medical prophylaxis; O: other; UI: Unknown indication; Diagnosis: see site list, only for treatment intention Reason in notes: Y/N IF YES HAI 1 HAI 2 HAI 3 Case definition code   Relevant device in situ before onset(3) O Yes O No O Unknown O Yes O No Present at admission Date of onset(4) ___ / ___ / _____ Origin of infection O current hospital O other hospital O other origin/ unk If BSI: source(5) MO-code R(6) Microorganism 1 Microorganism 2 Microorganism 3 (1) At the time of the survey, except for surgical prophylaxis 24h before 8:00 AM on the day of the survey; if yes, fill antimicrobial use data; (2) [infection with onset ≥ Day 3, OR SSI criteria met (surgery in previous 30d/1yr), OR discharged from acute care hospital <48h ago, OR CDI and discharged from acute care hospital < 28 days ago OR onset < Day 3 after invasive device/procedure on D1 or D2] AND [HAI case criteria met on survey day OR patient is receiving (any) treatment for HAI AND case criteria are met between D1 of treatment and survey day]; if yes, fill HAI data (3) relevant device use (intubation for PN, CVC/PVC for BSI, urinary catheter for UTI) in 48 hours before onset of infection (even intermittent use), 7 days for UTI; (4) Only for infections not present/active at admission (dd/mm/yyyy); (5) C-CVC, C-PVC, S-PUL, S-UTI, S-DIG, S-SSI, S-SST, S-OTH, UO, UNK; (6) AMR marker 0,1,2 or 9, see table

Form B1. Light option: Ward denominator data European Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use Form B1. Light option: Ward denominator data Survey date1: ___ / ___ / _______ Hospital code dd / mm / yyyy Ward name (abbr.) /Unit Id Ward specialty2 Total number of patients in ward3 Number of patients by consultant/patient specialty: Consultant/patient Specialty Number of patients in ward3   1Patients on the same ward should be included on a single day if possible 2Main ward specialty: >=80% of patients belong to this specialty, otherwise choose mixed ward 3Admitted to the ward before or at 8:00 AM and not discharged from the ward at time of the survey